![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 29, 26796-26804, July 22, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the
Departments of
Biochemistry and Molecular Biophysics, ¶Internal Medicine, and ||Chemistry, Washington University School of Medicine, St. Louis, Missouri 63110
The epidermal growth factor (EGF) receptor partitions into lipid rafts made using a detergent-free method, but is extracted from low density fractions by Triton X-100. By screening several detergents, we identified Brij 98 as a detergent in which the EGF receptor is retained in detergent-resistant membrane fractions. To identify the difference in lipid composition between those rafts that harbored the EGF receptor (detergent-free and Brij 98-resistant) and those that did not (Triton X-100-resistant), we used multidimensional electrospray ionization mass spectrometry to perform a lipidomics study on these three raft preparations. Although all three raft preparations were similarly enriched in cholesterol, the EGF receptor-containing rafts contained more ethanolamine glycerophospholipids and less sphingomyelin than did the non-EGF receptor-containing Triton X-100 rafts. As a result, the detergent-free and Brij 98-resistant rafts exhibited a balance of inner and outer leaflet lipids, whereas the Triton X-100 rafts contained a preponderance of outer leaflet lipids. Furthermore, in all raft preparations, the outer leaflet phospholipid species were significantly different from those in the bulk membrane, whereas the inner leaflet lipids were quite similar to those found in the bulk membrane. These findings indicate that the EGF receptor is retained only in rafts that exhibit a lipid distribution compatible with a bilayer structure and that the selection of phospholipids for inclusion into rafts occurs mainly on the outer leaflet lipids.
Received for publication, April 7, 2005 , and in revised form, May 9, 2005.
* This work was supported by National Institutes of Health Grants GM64491 (to L. J. P.), PO1 HL57278 (to R. W. G. and X. H), and RO1 HL41250 (to R. W. G.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains Supplemental Tables 13.
To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biophysics, Washington University School of Medicine, P. O. Box 8231, 660 S. Euclid Ave., St. Louis, MO 63110. Tel.: 314-362-9502; Fax: 314-362-7183; E-mail: pike{at}wustl.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Fedida-Metula, S. Elhyany, S. Tsory, S. Segal, M. Hershfinkel, I. Sekler, and D. Fishman Targeting lipid rafts inhibits protein kinase B by disrupting calcium homeostasis and attenuates malignant properties of melanoma cells Carcinogenesis, August 1, 2008; 29(8): 1546 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pasrija, S. L. Panwar, and R. Prasad Multidrug Transporters CaCdr1p and CaMdr1p of Candida albicans Display Different Lipid Specificities: both Ergosterol and Sphingolipids Are Essential for Targeting of CaCdr1p to Membrane Rafts Antimicrob. Agents Chemother., February 1, 2008; 52(2): 694 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yang, M. A. Raymond-Stintz, W. Ying, J. Zhang, D. S. Lidke, S. L. Steinberg, L. Williams, J. M. Oliver, and B. S. Wilson Mapping ErbB receptors on breast cancer cell membranes during signal transduction J. Cell Sci., August 15, 2007; 120(16): 2763 - 2773. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adachi, T. Nagao, H. I. Ingolfsson, F. R. Maxfield, O. S. Andersen, L. Kopelovich, and I. B. Weinstein The Inhibitory Effect of (-)-Epigallocatechin Gallate on Activation of the Epidermal Growth Factor Receptor Is Associated with Altered Lipid Order in HT29 Colon Cancer Cells Cancer Res., July 1, 2007; 67(13): 6493 - 6501. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Surviladze, K. A. Harrison, R. C. Murphy, and B. S. Wilson Fc{epsilon}RI and Thy-1 domains have unique protein and lipid compositions J. Lipid Res., June 1, 2007; 48(6): 1325 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bartz, W.-H. Li, B. Venables, J. K. Zehmer, M. R. Roth, R. Welti, R. G. W. Anderson, P. Liu, and K. D. Chapman Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic, J. Lipid Res., April 1, 2007; 48(4): 837 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sengupta, M. J. Ruano, F. Tebar, U. Golebiewska, I. Zaitseva, C. Enrich, S. McLaughlin, and A. Villalobo Membrane-permeable Calmodulin Inhibitors (e.g. W-7/W-13) Bind to Membranes, Changing the Electrostatic Surface Potential: DUAL EFFECT OF W-13 ON EPIDERMAL GROWTH FACTOR RECEPTOR ACTIVATION J. Biol. Chem., March 16, 2007; 282(11): 8474 - 8486. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Hunter and G. F. Nixon Spatial Compartmentalization of Tumor Necrosis Factor (TNF) Receptor 1-dependent Signaling Pathways in Human Airway Smooth Muscle Cells: LIPID RAFTS ARE ESSENTIAL FOR TNF-{alpha}-MEDIATED ACTIVATION OF RhoA BUT DISPENSABLE FOR THE ACTIVATION OF THE NF-{kappa}B AND MAPK PATHWAYS J. Biol. Chem., November 10, 2006; 281(45): 34705 - 34715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kasai, T. Shima, and M. Okada Role of Src family tyrosine kinases in the down-regulation of epidermal growth factor signaling in PC12 cells Genes Cells, December 1, 2005; 10(12): 1175 - 1187. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |